Day: April 29, 2025

WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today informed shareholders about several differences between holding shares in Direct Registration System (“DRS”) accounts and holding them in brokerage accounts. A DRS account is an alternative to using a brokerage account and Tevogen encourages shareholders to explore the differences. DRS accounts ensure your shares are registered directly in your name and not held through intermediary brokers, allowing shareholder to exercise direct control over their shares. DRS accounts may also have reduced transaction and account maintenance costs for shareholders. Brokerage accounts may provide greater access to tools, and selling shares in this type of account may be quicker when compared to a DRS account. Investors may also...

Novaturas announces that due to objective circumstances, the publication date of the audited financial statement for 2024 has been rescheduled. The report is planned to be released on June 12, 2025. The revised publication date is due to the processes of audit and internal financial report preparation taking longer than planned. The complexity of these processes is related to additional assessments of reconciliation of balances with overseas suppliers and some adjustments to the information required. It is recalled that during the 2023 audit, the management of Novaturas initiated a reconciliation of balances with suppliers for prior periods (up to 2022). The scope of this exercise and outstanding revised responses from certain suppliers delayed the process. As a result, the company’s 2023 financial statements included a qualification,...

AB “Novaturas” plans to publish regulated and investors related information for the year 2025 on the following dates:09 06 2025               Decisions of Annual General Meeting of ShareholdersTill 07 07 2025          Decisions of Annual General Meeting of Shareholders19 08 2025               Interim consolidated financial statements for 6 months of 202527 02 2026               Interim consolidated financial statements for 12 months of 2025 Darius UndzėnasCFO+370 678 05749

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (Nasdaq: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody therapies, announces today announced that it has entered into an agreement with institutional investors that are existing holders of warrants to purchase shares of common stock of the Company for cash (the “Existing Warrants”), wherein the investors agreed to exercise the Existing Warrants to purchase 5,626,685 shares of common stock at a reduced exercise price of $1.11 per share, resulting in gross proceeds of approximately $6.2 million, before deducting advisory fees and certain other expenses. The Company intends to use the net proceeds for working capital and other general corporate purposes. In consideration for the exercise of the Existing Warrants for cash, the investors received...

Luxembourg – 29 April 2025 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a substantial1 engineering, procurement, construction, and installation (EPCI) contract by bp to Subsea Integration Alliance (SIA) for the Ginger project offshore Trinidad and Tobago. The Ginger project is a notable project award under the new global framework agreement between bp and Subsea Integration Alliance partners SLB OneSubsea and Subsea7. Building on a long-standing successful relationship, this agreement establishes a new way of working that enables system-level optimisation through increased transparency and early engagement. Further, the framework defines a novel commercial model that effectively aligns incentives for accelerated and maximised value creation among all stakeholders involved, throughout the life of joint projects. For...

Audited annual report 2024 of AS Pro Kapital Grupp The Supervisory Board of AS Pro Kapital Grupp has approved the Group’s audited annual report for 2024. In 2024, AS Pro Kapital Grupp (hereafter referred to as the Group) revenue amounted to 18.2 million euros, representing a decrease of 4.9 million euros compared to the previous financial year. The decrease in revenue resulted from lower sales volumes, as most of the available units had already been sold, and the Group’s main focus in 2024 remained on the construction of new development projects. In Tallinn, the Group continued with the construction of the final stage of the Kalaranna District and began handing over the first completed units in December 2024. At the same time, new projects Uus-Kindrali in Tallinn and Šaltinių Namai Attico in Vilnius were launched, with both scheduled for...

Audited annual report 2024 of AS Pro Kapital Grupp The Supervisory Board of AS Pro Kapital Grupp has approved the Group’s audited annual report for 2024. In 2024, AS Pro Kapital Grupp (hereafter referred to as the Group) revenue amounted to 18.2 million euros, representing a decrease of 4.9 million euros compared to the previous financial year. The decrease in revenue resulted from lower sales volumes, as most of the available units had already been sold, and the Group’s main focus in 2024 remained on the construction of new development projects. In Tallinn, the Group continued with the construction of the final stage of the Kalaranna District and began handing over the first completed units in December 2024. At the same time, new projects Uus-Kindrali in Tallinn and Šaltinių Namai Attico in Vilnius were launched, with both scheduled for...